Women who experience premature menopause either due to surgical treatment or reproductive organ failure may have a higher risk of cognitive problems later in life, according to a large, multisite study in France published May 7 in the international journal of obstetrics and gynecology, BJOG.

Piramal Imaging announced today that the company has settled into a global license agreement with Swiss bioresearch firm AC Immune for further development and commercialization of tau-protein PET agents designed to aid in the diagnosis of neurodegenerative disease, including Alzheimer’s disease (AD).

Boston-based AG Mednet announced yesterday that the software company would be partnering with board-certified radiologists from Imaging Endpoints to improve the latter's clinical trial submission quality and compliance.

The Centers for Medicare & Medicaid Services (CMS) is projected to publish a final rule on “burdensome” regulations regarding imaging in ambulatory surgical centers (ASC) and radiopharmaceutical preparation in hospitals on May 12.

Navidea Biopharmaceuticals, developers of Lymphoseek and novel NAV4694 announced its first quarter 2014 financial report Wednesday including word of $752,000 revenue over absolutely zero revenue for that period last year.

IBA Molecular announced today that the company will spearhead development and manufacture of Actinium Pharmaceuticals’ radioimmunotherapy for acute and refractory myeloid leukemia patients who need bone marrow transplants.

Kapil Dhingra, MBBS, previously the head of Roche Oncology, has been made a member of the board for radiopharmaceutical developers Advanced Accelerator Applications (AAA), the company announced last week.

A particular genetic allele is now deemed a protector of memory in the aging brain as demonstrated by combined genetic testing and functional MRI, according to a study published May 1 in Biological Psychology.